Cargando…
Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6(+)CD4(+) T Cells
Chemokine receptor type 6 (CCR6)(+)CD4(+) T cells are preferentially infected and depleted during HIV disease progression, but are preserved in non-progressors. CCR6 is expressed on a heterogeneous population of memory CD4(+) T cells that are critical to mucosal immunity. Preferential infection of t...
Autores principales: | Lafferty, Mark K., Sun, Lingling, Christensen-Quick, Aaron, Lu, Wuyuan, Garzino-Demo, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454423/ https://www.ncbi.nlm.nih.gov/pubmed/28509877 http://dx.doi.org/10.3390/v9050111 |
Ejemplares similares
-
CCR6 mediates the intracellular HIV inhibitory activity of human beta-defensin 2
por: Sun, Lingling, et al.
Publicado: (2006) -
Human Beta-Defensin 2 and 3 Inhibit HIV-1 Replication in Macrophages
por: Bharucha, Jennifer P., et al.
Publicado: (2021) -
Human beta-defensins induce APOBEC3G expression by interacting with chemokine receptors, protecting highly susceptible cells from HIV infection
por: Garzino-Demo, Alfredo, et al.
Publicado: (2012) -
The θ‐defensin retrocyclin 101 inhibits TLR4‐ and TLR2‐dependent signaling and protects mice against influenza infection
por: Prantner, Daniel, et al.
Publicado: (2017) -
Decreased MIP-3α Production from Antigen-Activated PBMCs in Symptomatic HIV-Infected Subjects
por: Zhang, Fuchun, et al.
Publicado: (2021)